British Columbia-based Tilray, a global producer of medical cannabis, announced it has signed a Letter of Intent with Québec to supply the province with cannabis. Tilray will supply Quebec with up to 5,000 kg of cannabis per year, bringing both its own brands and brands it has licensed.
The LOI helps secure a supply of cannabis for Quebec in the run-up to the legalization of adult use cannabis expected this coming summer.
Tilray serves tens of thousands of customers in eight countries spanning four continents. Tilray-branded medical products will continue to be sold exclusively in pharmacies and online.
Tilray is Good Manufacturing Practice (GMP) certified in accordance with the European Union standards. The company dispenses its products in hospitals, pharmacies and clinical trials in eight countries spanning four continents.